Published in Curr Opin Cell Biol on March 18, 2008
Aging, cellular senescence, and cancer. Annu Rev Physiol (2012) 5.08
Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer (2009) 5.02
Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence. Cancer Cell (2010) 3.81
Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest (2013) 3.47
The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence. Genes Dev (2009) 3.04
p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype. EMBO J (2011) 2.61
A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen. PLoS One (2010) 2.38
DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion. J Cell Sci (2010) 2.34
Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype. J Biol Chem (2011) 2.11
The interaction between Myc and Miz1 is required to antagonize TGFbeta-dependent autocrine signaling during lymphoma formation and maintenance. Genes Dev (2010) 1.81
Melanoma proliferation and chemoresistance controlled by the DEK oncogene. Cancer Res (2009) 1.61
BRD4 Connects Enhancer Remodeling to Senescence Immune Surveillance. Cancer Discov (2016) 1.54
The role of autophagy in tumour development and cancer therapy. Expert Rev Mol Med (2009) 1.43
RB1, development, and cancer. Curr Top Dev Biol (2011) 1.37
Age-associated increase in heterochromatic marks in murine and primate tissues. Aging Cell (2010) 1.33
Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer. Oncogene (2011) 1.32
H3K4 demethylation by Jarid1a and Jarid1b contributes to retinoblastoma-mediated gene silencing during cellular senescence. Proc Natl Acad Sci U S A (2012) 1.28
Induction of autophagy and inhibition of melanoma growth in vitro and in vivo by hyperactivation of oncogenic BRAF. J Invest Dermatol (2010) 1.27
Epithelial-mesenchymal transition induced by senescent fibroblasts. Cancer Microenviron (2011) 1.26
p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes. J Cell Biol (2013) 1.25
Translational control of cell growth and malignancy by the CPEBs. Nat Rev Cancer (2013) 1.24
Esophageal cancer-related gene 4 is a secreted inducer of cell senescence expressed by aged CNS precursor cells. Proc Natl Acad Sci U S A (2010) 1.24
The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence. Aging (Albany NY) (2009) 1.19
Cell senescence: role in aging and age-related diseases. Interdiscip Top Gerontol (2014) 1.14
Telomere loss provokes multiple pathways to apoptosis and produces genomic instability in Drosophila melanogaster. Genetics (2008) 1.10
The specific role of pRb in p16 (INK4A) -mediated arrest of normal and malignant human breast cells. Cell Cycle (2012) 1.10
Activation of Bmp2-Smad1 signal and its regulation by coordinated alteration of H3K27 trimethylation in Ras-induced senescence. PLoS Genet (2011) 1.10
MicroRNA regulation of ionizing radiation-induced premature senescence. Int J Radiat Oncol Biol Phys (2010) 1.08
Both decreased and increased SRPK1 levels promote cancer by interfering with PHLPP-mediated dephosphorylation of Akt. Mol Cell (2014) 1.06
Akt phosphorylates the transcriptional repressor bmi1 to block its effects on the tumor-suppressing ink4a-arf locus. Sci Signal (2012) 1.06
Controversial aspects of oncogene-induced senescence. Cell Cycle (2012) 1.04
Epithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths. Aging (Albany NY) (2010) 1.03
p53 and p16(INK4A) independent induction of senescence by chromatin-dependent alteration of S-phase progression. Nat Commun (2011) 1.00
Mitochondrial DNA damage induces apoptosis in senescent cells. Cell Death Dis (2013) 1.00
The replicometer is broken: telomeres activate cellular senescence in response to genotoxic stresses. Aging Cell (2014) 1.00
NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2. J Cell Biol (2015) 0.99
The histone demethylase Jarid1b (Kdm5b) is a novel component of the Rb pathway and associates with E2f-target genes in MEFs during senescence. PLoS One (2011) 0.98
A role for Mediator complex subunit MED13L in Rb/E2F-induced growth arrest. Oncogene (2012) 0.95
Activation of p53 with Nutlin-3a radiosensitizes lung cancer cells via enhancing radiation-induced premature senescence. Lung Cancer (2013) 0.93
Inhibition of TWIST1 leads to activation of oncogene-induced senescence in oncogene-driven non-small cell lung cancer. Mol Cancer Res (2013) 0.93
3'UTR elements inhibit Ras-induced C/EBPβ post-translational activation and senescence in tumour cells. EMBO J (2011) 0.91
TCEAL7 inhibition of c-Myc activity in alternative lengthening of telomeres regulates hTERT expression. Neoplasia (2010) 0.90
The Conundrum of Genetic "Drivers" in Benign Conditions. J Natl Cancer Inst (2016) 0.90
Thrombospondin-1 mediates oncogenic Ras-induced senescence in premalignant lung tumors. J Clin Invest (2013) 0.90
58-kDa microspherule protein (MSP58) is novel Brahma-related gene 1 (BRG1)-associated protein that modulates p53/p21 senescence pathway. J Biol Chem (2012) 0.89
Androgen receptor drives cellular senescence. PLoS One (2012) 0.89
Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy. J Pathol (2014) 0.87
The retinoblastoma protein selectively represses E2F1 targets via a TAAC DNA element during cellular senescence. J Biol Chem (2012) 0.87
E2F1-dependent oncogenic addiction of melanoma cells to MDM2. Oncogene (2011) 0.87
Of flies, mice, and men: evolutionarily conserved tissue damage responses and aging. Dev Cell (2015) 0.86
VentX trans-activates p53 and p16ink4a to regulate cellular senescence. J Biol Chem (2011) 0.86
Sprouty1 is a candidate tumor-suppressor gene in medullary thyroid carcinoma. Oncogene (2011) 0.86
How to measure RNA expression in rare senescent cells expressing any specific protein such as p16Ink4a. Aging (Albany NY) (2013) 0.86
Overexpression of the DEC1 protein induces senescence in vitro and is related to better survival in esophageal squamous cell carcinoma. PLoS One (2012) 0.85
Sequential inductions of the ZEB1 transcription factor caused by mutation of Rb and then Ras proteins are required for tumor initiation and progression. J Biol Chem (2013) 0.84
Discovery of piperlongumine as a potential novel lead for the development of senolytic agents. Aging (Albany NY) (2016) 0.83
STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence. Cell Cycle (2016) 0.83
Interleukin-4 induces senescence in human renal carcinoma cell lines through STAT6 and p38 MAPK. J Biol Chem (2013) 0.80
Induction of a tumor-associated activating mutation in protein tyrosine phosphatase Ptpn11 (Shp2) enhances mitochondrial metabolism, leading to oxidative stress and senescence. J Biol Chem (2013) 0.80
Inactivation of heat shock factor Hsf4 induces cellular senescence and suppresses tumorigenesis in vivo. Mol Cancer Res (2012) 0.80
Histone methylation and aging: lessons learned from model systems. Biochim Biophys Acta (2014) 0.79
Simvastatin suppresses breast cancer cell proliferation induced by senescent cells. Sci Rep (2015) 0.79
Sprouty1 induces a senescence-associated secretory phenotype by regulating NFκB activity: implications for tumorigenesis. Cell Death Differ (2013) 0.79
Heparan sulfation is essential for the prevention of cellular senescence. Cell Death Differ (2015) 0.78
Rheb phosphorylation is involved in p38-regulated/activated protein kinase-mediated tumor suppression in liver cancer. Oncol Lett (2015) 0.77
Suppression of the senescence-associated secretory phenotype (SASP) in human fibroblasts using small molecule inhibitors of p38 MAP kinase and MK2. Biogerontology (2015) 0.77
p14ARF post-transcriptional regulation of nuclear cyclin D1 in MCF-7 breast cancer cells: discrimination between a good and bad prognosis? PLoS One (2012) 0.77
Cellular Senescence is a Common Characteristic Shared by Preneoplasic and Osteo-Arthritic Tissue. Open Rheumatol J (2010) 0.77
Cellular senescence in livers from children with end stage liver disease. PLoS One (2010) 0.76
Aging, nutrient signaling, hematopoietic senescence, and cancer. Crit Rev Oncog (2013) 0.75
Cr(VI) induces premature senescence through ROS-mediated p53 pathway in L-02 hepatocytes. Sci Rep (2016) 0.75
Cellular Senescence and Lung Function during Aging. Yin and Yang. Ann Am Thorac Soc (2016) 0.75
Senescence and NFκB: A trojan horse in tumors? Oncoimmunology (2012) 0.75
CD95 ligand induces senescence in mismatch repair-deficient human colon cancer via chronic caspase-mediated induction of DNA damage. Cell Death Dis (2017) 0.75
BZLF1 Attenuates Transmission of Inflammatory Paracrine Senescence in Epstein-Barr Virus-Infected Cells by Downregulating Tumor Necrosis Factor Alpha. J Virol (2016) 0.75
Metallothionein Prevents Age-Associated Cardiomyopathy via Inhibiting NF-κB Pathway Activation and Associated Nitrative Damage to 2-OGD. Antioxid Redox Signal (2016) 0.75
Epigenetic alteration to activate Bmp2-Smad signaling in Raf-induced senescence. World J Biol Chem (2016) 0.75
MK3 modulation affects BMI1-dependent and independent cell cycle check-points. PLoS One (2015) 0.75
Identification of senescent cell surface targetable protein DPP4. Genes Dev (2017) 0.75
The Immortal Senescence. Methods Mol Biol (2017) 0.75
Mitochondrial determinants of cancer health disparities. Semin Cancer Biol (2017) 0.75
BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature (2005) 16.87
Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell (2008) 9.22
The essence of senescence. Genes Dev (2010) 8.21
Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer (2009) 5.02
Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature (2004) 4.53
The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol (2005) 4.29
KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer (2006) 4.14
A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Nature (2013) 3.46
Metastasis mechanisms. Biochim Biophys Acta (2009) 2.51
Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis. Proc Natl Acad Sci U S A (2013) 2.12
Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis. Genes Dev (2012) 2.06
The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes Dev (2008) 1.93
A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis. Mol Cell Biol (2009) 1.74
E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest. Cancer Cell (2002) 1.59
Critical role for TrkB kinase function in anoikis suppression, tumorigenesis, and metastasis. Cancer Res (2007) 1.56
Deregulating EMT and senescence: double impact by a single twist. Cancer Cell (2008) 1.29
The neurotrophic receptor TrkB in anoikis resistance and metastasis: a perspective. Cancer Res (2005) 1.07
Epithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths. Aging (Albany NY) (2010) 1.03
Genome-wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma. Pigment Cell Melanoma Res (2013) 1.02
Impact papers on aging in 2009. Aging (Albany NY) (2010) 0.89
Functional identification of LRF as an oncogene that bypasses RASV12-induced senescence via upregulation of CYCLIN E. Carcinogenesis (2009) 0.85
Evidence of oncogene-induced senescence in thyroid carcinogenesis. Endocr Relat Cancer (2011) 0.84
Cooperative induction of apoptosis in NRAS mutant melanoma by inhibition of MEK and ROCK. Pigment Cell Melanoma Res (2015) 0.83
SUMOylation of DRIL1 directs its transcriptional activity towards leukocyte lineage-specific genes. PLoS One (2009) 0.83
Detailed imaging and genetic analysis reveal a secondary BRAF(L505H) resistance mutation and extensive intrapatient heterogeneity in metastatic BRAF mutant melanoma patients treated with vemurafenib. Pigment Cell Melanoma Res (2015) 0.83
Antagonistic TSC22D1 variants control BRAF(E600)-induced senescence. EMBO J (2011) 0.82
Functional characterization of human cancer-derived TRKB mutations. PLoS One (2011) 0.81
Near-genomewide RNAi screening for regulators of BRAF(V600E) -induced senescence identifies RASEF, a gene epigenetically silenced in melanoma. Pigment Cell Melanoma Res (2014) 0.79
Ageing: Old cells under attack. Nature (2011) 0.79
Comment on "Absence of senescence-associated beta-galactosidase activity in human melanocytic nevi in vivo". J Invest Dermatol (2008) 0.78
Interrogating open issues in cancer medicine with patient-derived xenografts. Nat Rev Cancer (2017) 0.75
If you can't beat me, join me: collaborating oncogenes circumventing senescence and causing cancer. Pigment Cell Melanoma Res (2011) 0.75